Clostridium difficile infection

Article, Other literature type English OPEN
Smits, Wiep Klaas ; Lyras, Dena ; Lacy, D. Borden ; Wilcox, Mark H. ; Kuijper, Ed J. (2016)

Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life threatening, especially in elderly people and in patients who have dysbiosis of the gut microbiota following antimicrobial drug exposure. C. difficile is the leading cause of health-care-associated infective diarrhoea. The life cycle of C. difficile is influenced by antimicrobial agents, the host immune system, and the host microbiota and its associated metabolites. The primary mediators of inflammation in C. difficile infection (CDI) are large clostridial toxins, toxin A (TcdA) and toxin B (TcdB), and, in some bacterial strains, the binary toxin CDT. The toxins trigger a complex cascade of host cellular responses to cause diarrhoea, inflammation and tissue necrosis - the major symptoms of CDI. The factors responsible for the epidemic of some C. difficile strains are poorly understood. Recurrent infections are common and can be debilitating. Toxin detection for diagnosis is important for accurate epidemiological study, and for optimal management and prevention strategies. Infections are commonly treated with specific antimicrobial agents, but faecal microbiota transplants have shown promise for recurrent infections. Future biotherapies for C. difficile infections are likely to involve defined combinations of key gut microbiota.
  • References (62)
    62 references, page 1 of 7

    104. Riegler, M. et al. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J.Clin.Invest 95, 2004-2011 (1995).

    105. Savidge, T. C. et al. Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine. Gastroenterology 125, 413-420 (2003).

    106. Chumbler, N. M. et al. Crystal structure of Clostridium difficile Toxin A. Nat.Microbiol. 1, - (2016).

    107. Pruitt, R. N. et al. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity. J.Biol.Chem. 287, 8013-8020 (2012).

    108. Papatheodorou, P., Zamboglou, C., Genisyuerek, S., Guttenberg, G. & Aktories, K. Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis. PLoS.One. 5, e10673- (2010).

    109. Pruitt, R. N. & Lacy, D. B. Toward a structural understanding of Clostridium difficile toxins A and B. Front. Cell. Infect. Microbiol. 2, 28 (2012).

    110. Greco, A. et al. Carbohydrate recognition by Clostridium difficile toxin A. Nat.Struct.Mol.Biol. 13, 460-461 (2006).

    111. Murase, T. et al. Structural basis for antibody recognition in the receptor-binding domains of toxins A and B from Clostridium difficile. J.Biol.Chem. 289, 2331-2343 (2014).

    112. Sauerborn, M., Leukel, P. & von Eichel-Streiber, C. The C-terminal ligand-binding domain of Clostridium difficile toxin A (TcdA) abrogates TcdA-specific binding to superoxide generation by interrupting the binding of regulatory subunits. Chem.Biol. 19, 752-763 (2012).

    131. Kuehne, S. A. et al. Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain. J.Infect.Dis. 209, 83-86 (2014).

  • Related Research Results (1)
  • Similar Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark